GLP-1 receptor agonists in idiopathic subglottic stenosis: patient attitudes, barriers, facilitators and patient-reported outcomes
Purpose Idiopathic subglottic stenosis (iSGS) is a rare disease of unknown etiology. There has been a growing interest within the patient community regarding the potential therapeutic role of GLP-1 receptor agonists (GLP-1 RA) in the management of iSGS, potentially through weight loss-mediated or direct anti-inflammatory mechanisms. The objective of this study was to evaluate patient perspectives and attitudes regarding the potential role of GLP-1 RA in the overall management of iSGS. Methods We conducted a cross-sectional observational study through a structured online anonymous survey. The survey comprised 53 items organized across four domains: demographics; attitudes, barriers and facilitators to GLP-1 RA use; therapy details and adverse effects; and perceived therapeutic impact. Results A total of 1382 patients with iSGS completed the survey. Diagnostic delay of iSGS was a prominent finding, with patients reporting a substantial lag between symptom onset and confirmed diagnosis. Overall, 407 patients used GLP-1 RA therapy. Among GLP-1 RA users, 38.44% self-reported perceived improvement in airway symptoms. Key barriers to GLP-1 RA therapy included cost, access, and limited physician awareness. Thematic analysis of the patient’s responses revealed patients’ attitudes toward GLP-1 RA therapy were largely favorable, with patients citing anti-inflammatory benefits and quality of life improvements as primary motivators for use. Conclusion GLP-1 receptor agonists are generally viewed favorably by patients with iSGS. Patient-reported experiences suggest possible improvements in airway symptoms, although prospective studies are required to establish causality and clarify mechanistic benefit.
Authors
- Chadwan Al Yaghchi (ORCID: https://orcid.org/0000-0002-5771-5096)
- Laura-Élisabeth Gosselin (ORCID: https://orcid.org/0009-0007-6111-0288)
- Catherine Anderson (ORCID: https://orcid.org/0009-0007-5251-9532)
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Université Laval (CA)
- Imperial College London (GB)
Publication Details
- Journal
- European Archives of Oto-Rhino-Laryngology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s00405-026-10835-3
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00